Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasitic disease control initiatives exceed expectations
National schistosomiasis control programme activities in Tanzania.

Control of schistosomiasis ‘may be reached sooner than proposed’

Programmes to control and eliminate parasitic disease are reaching targets earlier than projected, according to new research.

Scientists analysed data from nine national schistosomiasis control programmes and found that the majority of initiatives across sub-Saharan African and Yemen have reached the disease-control target by two treatment rounds or less. This is contrary to the five to 10 years estimated by the World Health Organisation (WHO).


The collaborative study involved researchers at The London School of Hygiene & Tropical Medicine (LSHTM), the Royal Veterinary College (RVC) and the US Agency for International Development. Results are published in the New England Journal of Medicine.

“I’m excited to share the results of our paper which will enable us to improve our approach to achieving the global control and elimination targets for schistosomiasis, owing much to the hard work and dedication of staff at these control programmes,” said lead author Dr Arminder Deol from the LSHTM.


“We move beyond theoretical outputs, and present empirical evidence through our partnership with the National Ministries of Health, to show that the goal of control may be reached sooner than proposed, which means that we can adjust our strategy to ensure we meet the elimination targets in time.”

Schistosomiasis is a neglected tropical disease caused by parasitic worms. Estimates show that at least 220.8 million people needed preventative treatment for the infection in 2017, of which over 102.3 million people were reported to have been treated. 


People can become infected with schistosomiasis through agricultural, domestic and recreational activities that expose them to infested water. The parasites can cause symptoms including stunting, anaemia, fever, genital lesions and irreversible organ damage.

The WHO set ambitious goals to control schistosomiasis and eliminate it as a public health problem by 2020 and 2025, respectively. The strategy recommended by WHO is preventive chemotherapy with praziquantel - the only drug available.

Image (C) A. Deol.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.